NIH Director’s New Innovator Award Program (DP2) Deadline


Friday, August 12, 2022, 5:00pm

NIH Director’s New Innovator Award Program (DP2)
FAS/SEAS/OSP Deadline: August 12, 2022
Sponsor Deadline: August 19, 2022
Award Amount: $1,500,000 direct costs over five years

The NIH Director’s New Innovator Award Program supports early stage investigators of exceptional creativity who propose highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. For the program to support the best possible researchers and research, applications are sought which reflect the full diversity of the research workforce. Individuals from diverse backgrounds, including those from underrepresented groups and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research.

Applicants must meet the definition of an Early Stage Investigator (ESI) at the time of application submission. An ESI is a new investigator (defined as a PD/PI who has not competed successfully for a significant NIH independent research award) who is within 10 years of completing their terminal research degree or end of post-graduate clinical training. Awardees are required to commit at least three person-months (25%) of their research effort each year to activities supported by the New Innovator Award.